Intensive Care Anxiety in SARS-CoV-2 Patients

Intensive Care Anxiety in SARS-CoV-2 (COVID 19) Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04715477

Enrollment

100

Registered

2021-01-20

Start date

2021-01-17

Completion date

2021-04-15

Last updated

2021-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Interventions

BEHAVIORALHospital Anxiety Depression Measure

Hospital Anxiety Depression Measure

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Above 18 years old * COVID PCR +, * admitted to intensive care, * conscious, cooperative patients

Exclusion criteria

* Having hearing and speaking problems, * Can't speak Turkish or English, * who do not have the cognitive level to understand and answer the questions, * Communication problems such as dementia and Alzheimer's, * patients receiving sedation

Design outcomes

Primary

Measure	Time frame	Description
intensive care Anxiety	3 month	Hospital Anxiety Depression scale

Countries

Turkey (Türkiye)

Contacts

Primary Contactilke kupeli

ilkeser2004@gmail.com05555485632

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026